Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Roche now operates over 3,500 Nvidia Blackwell GPUs for AI-driven drug discovery, making it the pharma industry's largest ...

Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience.

The companies developing new weight-loss medicines have a problem: the balance of power has shifted, and patients are bailing out of their clinical trials.

Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience.

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Clinical decision support (CDS) software plays an increasingly central role in health-care delivery, yet the ambiguous interpretations of regulations result in inconsistent application in clinical ...

The European Medicines Agency (EMA) has designated as an orphan drug a compound based on the bioactive lipid molecule Maresin-1 (MaR1), currently ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...

Comprehensive, up-front full-panel NGS across lung cancer stages is preferred to conserve tissue and avoid sequential testing ...

While many in the biotechnology sector expressed excitement for faster drug approval timelines, some researchers voiced ...